Chlorantraniliprole Patent Landscape Analysis

Originating from E.I. du Pont de Nemours and now forming the foundation of FMC’s Rynaxypyr® insect-control portfolio, chlorantraniliprole is one of the world’s most commercially important diamide insecticides. Its rapid feeding cessation, extended residual activity and broad crop applicability have made it an industry-leading technology, registered in more than 120 countries. FMC Rynaxypyr technology

The report retains 908 patent families across 475 consolidated owner groups. Combination development dominates, comprising 515 families, with 133 single-active formulation families. The retained commercialisation routes account for 862 of the 908 families.

A total of 479 families have a grant or national pending reading, while 42 live families reach their nominal term within five years—highlighting both the continuing density of protection and the approaching opportunities created by portfolio expiry.

This 193-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, followed by a complete directory of all 475 owner groups. Detailed patent tables identify holder, parent filing, claimed subject matter, priority, family members, status and term for every retained family.

Not a freedom-to-operate opinion.